Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research and Treatment
Published in: Breast Cancer Research and Treatment 3/2000

01-04-2000

Carcinoma in situ of the breast: correlation of histopathology to immunohistochemical markers and DNA ploidy

Authors: Gyda Lolk Ottesen, Ib Jarle Christensen, Jørgen K. Larsen, Jacob Larsen, Bo Baldetorp, Thomas Linden, Bodil Hansen, Johan Andersen

Published in: Breast Cancer Research and Treatment | Issue 3/2000

Login to get access
Metadata
Title
Carcinoma in situ of the breast: correlation of histopathology to immunohistochemical markers and DNA ploidy
Authors
Gyda Lolk Ottesen
Ib Jarle Christensen
Jørgen K. Larsen
Jacob Larsen
Bo Baldetorp
Thomas Linden
Bodil Hansen
Johan Andersen
Publication date
01-04-2000
Publisher
Kluwer Academic Publishers
Published in
Breast Cancer Research and Treatment / Issue 3/2000
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1023/A:1006453420088

Other articles of this Issue 3/2000

Breast Cancer Research and Treatment 3/2000 Go to the issue

OriginalPaper

Aberrant expression of TSG101 in Taiwan Chinese breast cancer

OriginalPaper

Temporal in vitro expansion of the luminal lineage of human mammary epithelial cells achieved with the 3T3 feeder layer technique

OriginalPaper

Concurrent adjuvant chemotherapy and immediate breast reconstruction with skin expanders after mastectomy for breast cancer

OriginalPaper

Evaluation of stereotactic core needle biopsy (SCNB) of the breast at a single institution

OriginalPaper

Pain experienced by women attending breast cancer screening

OriginalPaper

The timing of treatment in breast cancer: gaps and delays in treatment can be harmful
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits